Mother-to-Child transmission of human T-cell lymphotropic viruses-1/2: What we know, and what are the gaps in understanding and preventing this route of infection

Journal of the Pediatric Infectious Diseases Society

Volumn 3, Issue SUPPL1, 2014, Pages

  Carneiro Proietti, A B F ^a   Amaranto Damasio, M S ^a   Leal Horiguchi, C F ^a   Bastos, R H C ^a   Seabra Freitas, G ^a   Borowiak, D R ^a   Ribeiro, M A ^a   Proietti, F A ^a   Ferreira, A S D ^a   Martins, M L ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Breastfeeding; HTLV; Human T cell lymphotropic viruses; Perinatal transmission; Prevention

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD TRANSFUSION; BLOODSTREAM INFECTION; BREAST FEEDING; CESAREAN SECTION; CONCURRENT SEXUAL PARTNERSHIP; DRUG ABUSE; GENITAL ULCER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MENTAL STRESS; MIXED INFECTION; NONHUMAN; OBSTETRIC PROCEDURE; PATIENT COUNSELING; PLACENTAL TRANSFER; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; SEXUAL TRANSMISSION; STRONGYLOIDES STERCORALIS; UNPROTECTED SEX; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 84949118955     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu070     Document Type: Article

References (40)

1. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218: 571-3.
2. Poiez BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultures lymphocytes or a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-9.
3. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058-68.
4. Proietti AB. HTLV. Vol. 15. Hemominas Fundação ed, Belo Horizonte, Brazil;2010.
5. Calattini S, Chevalier AS, Duprez R, et al. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2005;2:30.
6. Wolfe ND, Heneine W, Carr JK, et al. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A 2005;102:7994-9.
7. Kurth R, Bannert N. Retroviruses: Molecular Biology, Genomics and Pathogenesis. UK: Caister Academic Press;2010.
8. Verdonck K, González E, Van Dooren S, et al. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007;7:266-81.
9. Fujiyoshi T, Li HC, Lou H, et al. Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses 1999;15:1235-9.
10. Li HC, Fujiyoshi T, Lou H, et al. The presence of ancient human T-cell lymphotropic virus type I provirus DNA in an Andean mummy. Nat Med 1999;5:1428-32.
11. Orellana N, Mayo A, Otsuki K, Paulo AC. HTLV in pre-Columbian mummies in Bolivia. In: Program and Abstracts of the 14th International Conference on Human Retrovirology HTLV and Related Retroviruses (Salvador). Salvador, Brazil;Retrovirology 2009;6:77.
12. Rego FF, Alcantara LC, Moura Neto JP, et al. HTLV type 1 molecular study in Brazilian villages with African characteristics giving support to the post-Columbian introduction hypothesis. AIDS Res Hum Retroviruses 2008;24:673-7.
13. Van Dooren S, Gotuzzo E, Salemi M, et al. Evidence for a post-Columbian introduction of human T-cell lymphotropic vírus [type I] [corrected] in Latin America. J Gen Virol 1998;79:2695-708.
14. Hall WW, Kubo T, Ijichi S, et al. Human T cell leukemia/ lymphoma virus, type II (HTLV-II): emergence of an important newly recognized pathogen. Semin Virol 1994;5:165-78.
15. Gonçalves DU, Proietti FA, Ribas JG, et al. Epidemiology, treatment and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 2010;23:577-89.
16. Koga Y, Iwanaga M, Soda M, et al. Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan. J Med Virol 2010;82:668-74.
17. Taylor GP, Bodéus M, Courtois F, et al. The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr 2005;38:104-9.
18. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection Lancet 1999;353:1951-8.
19. Bartholomew C, Saxinger WC, Clark JW, et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 1987;257:2604-8.
20. Murphy EL, Wilks R, Hanchard B, et al. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-1) in Jamaica. Int J Epidemiol 1996;25: 1083-9.
21. Catalan-Soares BC, Carneiro-Proietti AB, Proietti FA. HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population. Rev Saúde Pública 2003;37:470-6.
22. Murphy EL, Hanchard B, Figueroa JP, et al. Modeling the risk of ATLL in persons infected with HTLV-I. Int J Cancer 1989;43: 250-3.
23. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. Infect Dis 1993;167: 57-65.
24. Figueroa JP, Ward E, Morris J, et al. Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:232-7.
25. Roucoux DF, Wang B, Smith D, et al. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. Infect Dis 2005;191:1490-8.
26. Schreiber GB, Murphy EL, Horton JA, et al. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:263-71.
27. Sullivan MT, Williams AE, Fang CT, et al. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group. Arch Intern Med 1991;151:2043-8.
28. Manns A,Wilks RJ, Murphy EL, et al. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients Int J Cancer 1992;51: 886-91.
29. Donegan E, Busch MP, Galleshaw JA, et al. Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group Ann. Intern Med 1990;113:555-6.
30. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984;46:245-53.
31. Feigal E, Murphy E, Vranizan K, et al. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis 1991;164:36-42.
32. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992;326:375-80.
33. Lee H, Swanson P, Shorty VS, et al. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science 1989;244:471-5.
34. Murphy EL, Mahieux R, de Thé G, et al. Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO. Virology 1998;242:425-34.
35. Liu H, Leung P, Glynn S, Murphy EL. HTLV-II RFLP subtypes a0 and b4/b5 are associated with different demographic and geographic characteristics in the United States. Virology 2001;279: 90-6.
36. Fujino T, Nagata Y. HTLV-I transmission from mother to child. J Reprod Immunol 2000;47:197-206.
37. Trevino A, Aguilera A, Caballeo E, et al. Seroprevalence of HTLV-1 and 2 infection among native and immigrant pregnant women in Spain. AIDS Res Hum Retroviruses 2009;25:551-4.
38. Trenchi A, Gastaldello R, BalangeroM, et al. Retrospective study of the prevalence of human T-cell lymphotropic virus-type 1/2, HIV, and HBV in pregnant women in Argentina. J Med Virol 2007;79:1974-8.
39. Mansuy JM, Schlegel L, Villeneuve L, et al. Seroprevalence of retroviral infections among pregnant women in Martinique (French West Indies). Am J Trop Med Hyg 1999;61:598-9.
40. Alarcón JO, Friedman HB, Montano SM, et al. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in Peru. J Acquir Immune Defic Syndr 2006;42:604-9.